Clinical trials
Phase 1 Paresis trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
20 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2004 | 1 |
| 2008 | 2 |
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 3 |
| 2014 | 1 |
| 2016 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 9 |
| Recruiting | 5 |
| Unknown status | 4 |
| Active, not recruiting | 1 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Qilu Hospital of Shandong University | 2 |
| Axem Neurotechnology Inc. | 1 |
| Burke Medical Research Institute | 1 |
| Hasselt University | 1 |
| Hugo W. Moser Research Institute at Kennedy Krieger, Inc. | 1 |
| Johns Hopkins University | 1 |
| Kessler Foundation | 1 |
| Medical College of Wisconsin | 1 |
| Medical University of South Carolina | 1 |
| Nationwide Children's Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Paresis | 20 |
| Stroke | 15 |
| Ischemic Stroke | 4 |
| Cerebrovascular Disorders | 2 |
| Hemiplegia | 2 |
| Hemorrhagic Stroke | 2 |
| Paralysis | 2 |
| Brain Diseases | 1 |
| Brain Ischemia | 1 |
| Bronchiolitis Obliterans Syndrome | 1 |
Trials
Showing 76 to 20 of 20. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.